|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||31.56 mL||157.8 mL||315.61 mL|
|0.5 mM||6.31 mL||31.56 mL||63.12 mL|
|1 mM||3.16 mL||15.78 mL||31.56 mL|
|5 mM||0.63 mL||3.16 mL||6.31 mL|
*The above data is based on the productmolecular weight 316.85. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Activator|
|Storage||at -20°C 3 years Powder|
Tenovin-1 is a small molecule activator of p53 transcriptional activity that protects against MDM2-mediated p53 degradation.
RG7112 is the first clinical small-molecule MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.
Tenovin-6 is a analog of tenovin-1. Tenovin-6 inhibits the protein deacetylase activities of purified human SIRT1, SIRT2, and SIRT3 in vitr…
JNJ-26854165 is one of p53-activating agents and synergizes with AraC or doxorubicin to induce p53-mediated apoptosis and may provide a nove…
WR 1065, a dephosphorylated metabolite of amifostine (Ethyol), can protect against the immediate and delayed effects of radiation exposure.
RETRA hydrochloride is an antitumor agent which inhibits tumor cell growth in a mutant p53- and p73-dependent manner in vitro and iin vivo.